An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3‐L1 adipocytes
Authors:
- Hiroaki MasuzakiHMHiroaki Masuzaki
- Tomohiro TanakaTTTomohiro Tanaka
- Shintaro YasueSYShintaro Yasue
- Tsutomu TomitaTTTsutomu Tomita
- Kayoko OkazawaKOKayoko Okazawa
- Junji FujikuraJFJunji Fujikura
- Hideki ChushoHCHideki Chusho
- Ken EbiharaKEKen Ebihara
- Tatsuya HayashiTHTatsuya Hayashi
- Kiminori HosodaKHKiminori Hosoda
- Kazuwa NakaoKNKazuwa Nakao
- 25 September 2004
- journal article
- Published by Wiley in FEBS Letters
- Vol. 576 (3) , 492-497
Abstract
Evidence has accumulated that some of the angiotensin II AT1 receptor antagonists have insulin‐sensitizing property. We thus examined the effect of telmisartan on insulin action using 3T3‐L1 adipocytes. With standard differentiation inducers, a higher dose of telmisartan effectively facilitated differentiation of 3T3‐L1 preadipocytes. Treatment of both differentiating adipocytes and fully differentiated adipocytes with telmisartan caused a dose‐dependent increase in mRNA levels for PPARγ target genes such as aP2 and adiponectin. By contrast, telmisartan attenuated 11β‐hydroxysteroid dehydrogenase type 1 mRNA level in differentiated adipocytes. Of note, we demonstrated for the first time that telmisartan augmented GLUT4 protein expression and 2‐deoxy glucose uptake both in basal and insulin‐stimulated state of adipocytes, which may contribute, at least partly, to its insulin‐sensitizing ability.Keywords
This publication has 38 references indexed in Scilit:
- Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic MiceHypertension, 2004
- Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating ActivityHypertension, 2004
- Peroxisome Proliferator-activated Receptor-γ Represses GLUT4 Promoter Activity in Primary Adipocytes, and Rosiglitazone Alleviates This EffectJournal of Biological Chemistry, 2003
- Glitazones and Heart FailureCirculation, 2003
- New drug targets for type 2 diabetes and the metabolic syndromeNature, 2001
- Production of Angiotensin II Receptors Type One (AT1) and Type Two (AT2) During the Differentiation of 3T3-L1 PreadipocytesHormone and Metabolic Research, 2000
- PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes.Journal of Clinical Investigation, 1998
- Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk.Journal of Clinical Investigation, 1997
- The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stabilityEndocrinology, 1993
- Characterization of a polyclonal anti-peptide antibody to the angiotensin II type-1 (AT1) receptorBiochemical and Biophysical Research Communications, 1992